These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21163936)

  • 1. Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma.
    Leeman-Neill RJ; Seethala RR; Singh SV; Freilino ML; Bednash JS; Thomas SM; Panahandeh MC; Gooding WE; Joyce SC; Lingen MW; Neill DB; Grandis JR
    Cancer Prev Res (Phila); 2011 Feb; 4(2):230-7. PubMed ID: 21163936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 as a Chemoprevention Target in Carcinogen-Induced Head and Neck Squamous Cell Carcinoma.
    Peyser ND; Wang L; Zeng Y; Acquafondata M; Freilino M; Li H; Sen M; Gooding WE; Satake M; Wang Z; Johnson DE; Grandis JR
    Cancer Prev Res (Phila); 2016 Aug; 9(8):657-63. PubMed ID: 27267892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.
    Tang XH; Knudsen B; Bemis D; Tickoo S; Gudas LJ
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):301-13. PubMed ID: 14734483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bitter Melon Prevents the Development of 4-NQO-Induced Oral Squamous Cell Carcinoma in an Immunocompetent Mouse Model by Modulating Immune Signaling.
    Sur S; Steele R; Aurora R; Varvares M; Schwetye KE; Ray RB
    Cancer Prev Res (Phila); 2018 Apr; 11(4):191-202. PubMed ID: 29061560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-X(L) enhances antitumor effects in squamous cell carcinoma of the head and neck.
    Boehm AL; Sen M; Seethala R; Gooding WE; Freilino M; Wong SM; Wang S; Johnson DE; Grandis JR
    Mol Pharmacol; 2008 Jun; 73(6):1632-42. PubMed ID: 18326051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer.
    Bothwell KD; Shaurova T; Merzianu M; Suresh A; Kuriakose MA; Johnson CS; Hershberger PA; Seshadri M
    Cancer Prev Res (Phila); 2015 Sep; 8(9):765-76. PubMed ID: 26100522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3.
    Leeman-Neill RJ; Wheeler SE; Singh SV; Thomas SM; Seethala RR; Neill DB; Panahandeh MC; Hahm ER; Joyce SC; Sen M; Cai Q; Freilino ML; Li C; Johnson DE; Grandis JR
    Carcinogenesis; 2009 Nov; 30(11):1848-56. PubMed ID: 19762335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis.
    Hasina R; Martin LE; Kasza K; Jones CL; Jalil A; Lingen MW
    Cancer Prev Res (Phila); 2009 Apr; 2(4):385-93. PubMed ID: 19336725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
    Leeman-Neill RJ; Cai Q; Joyce SC; Thomas SM; Bhola NE; Neill DB; Arbiser JL; Grandis JR
    Clin Cancer Res; 2010 May; 16(9):2571-9. PubMed ID: 20388852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of erlotinib on epidermal growth factor receptor and downstream signaling in oral cavity squamous cell carcinoma.
    Tsien CI; Nyati MK; Ahsan A; Ramanand SG; Chepeha DB; Worden FP; Helman JI; D'Silva N; Bradford CR; Wolf GT; Lawrence TS; Eisbruch A
    Head Neck; 2013 Sep; 35(9):1323-30. PubMed ID: 22907806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system.
    Sriuranpong V; Park JI; Amornphimoltham P; Patel V; Nelkin BD; Gutkind JS
    Cancer Res; 2003 Jun; 63(11):2948-56. PubMed ID: 12782602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis.
    Zhou G; Hasina R; Wroblewski K; Mankame TP; Doçi CL; Lingen MW
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1493-502. PubMed ID: 20978113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.
    Tang XH; Albert M; Scognamiglio T; Gudas LJ
    Cancer Prev Res (Phila); 2009 Dec; 2(12):1100-10. PubMed ID: 19952362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells.
    Koch AT; Love-Homan L; Espinosa-Cotton M; Stanam A; Simons AL
    Cancer Res; 2015 Apr; 75(8):1657-67. PubMed ID: 25712126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitor erlotinib in head and neck cancer cells.
    Sobhakumari A; Schickling BM; Love-Homan L; Raeburn A; Fletcher EV; Case AJ; Domann FE; Miller FJ; Simons AL
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):736-45. PubMed ID: 23917044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.
    Shin DM; Zhang H; Saba NF; Chen AY; Nannapaneni S; Amin AR; Müller S; Lewis M; Sica G; Kono S; Brandes JC; Grist WJ; Moreno-Williams R; Beitler JJ; Thomas SM; Chen Z; Shin HJ; Grandis JR; Khuri FR; Chen ZG
    Clin Cancer Res; 2013 Mar; 19(5):1244-56. PubMed ID: 23422093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemopreventive effect of a mixture of Chinese Herbs (antitumor B) on chemically induced oral carcinogenesis.
    Wang Y; Yao R; Gao S; Wen W; Du Y; Szabo E; Hu M; Lubet RA; You M
    Mol Carcinog; 2013 Jan; 52(1):49-56. PubMed ID: 22086836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
    Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
    Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monensin inhibits epidermal growth factor receptor trafficking and activation: synergistic cytotoxicity in combination with EGFR inhibitors.
    Dayekh K; Johnson-Obaseki S; Corsten M; Villeneuve PJ; Sekhon HS; Weberpals JI; Dimitroulakos J
    Mol Cancer Ther; 2014 Nov; 13(11):2559-71. PubMed ID: 25189541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular features of tongue epithelium treated with the carcinogen 4-nitroquinoline-1-oxide and alcohol as a model for HNSCC.
    Osei-Sarfo K; Tang XH; Urvalek AM; Scognamiglio T; Gudas LJ
    Carcinogenesis; 2013 Nov; 34(11):2673-81. PubMed ID: 23784083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.